# Evo 2 API Capabilities Analysis

## Executive Summary
Evo 2 represents a breakthrough in biological foundation models, offering both discriminative and generative capabilities across all domains of life. This analysis focuses on the key API endpoints and computational mechanisms that enable these capabilities.

## 1. Discriminative API Capabilities

### 1.1 Zero-Shot Variant Effect Prediction (VEP)
**Core Mechanism:** Sequence likelihood change calculation
- **Input:** Wildtype sequence + variant
- **Output:** Delta likelihood score indicating functional impact
- **Key Innovation:** Works across coding/noncoding regions without task-specific training
- **Performance:** State-of-the-art for noncoding variants, competitive with AlphaMissense for coding SNVs

**API Pattern:**
```python
def predict_variant_impact(sequence_wt, sequence_mutant, context_window=8192):
    # Calculate log-likelihood difference
    delta_score = model.log_likelihood(sequence_mutant) - model.log_likelihood(sequence_wt)
    return delta_score  # Negative = deleterious, Positive = neutral
```

### 1.2 Pathogenicity Classification
**Core Mechanism:** Likelihood-based scoring across variant types
- **Supports:** SNVs, insertions, deletions in both coding and noncoding regions
- **Specialization:** Superior performance on non-SNV variants where other models fail
- **Clinical Applications:** BRCA1/BRCA2 variant interpretation, ClinVar classification

### 1.3 Gene Essentiality Prediction
**Core Mechanism:** Premature stop codon insertion analysis
- **Method:** Score likelihood of truncated protein sequences
- **Applications:** Drug target identification, synthetic lethality prediction
- **Scale:** Works across bacterial, phage, and human genomes

### 1.4 Protein Fitness Prediction
**Core Mechanism:** Sequence likelihood correlation with experimental fitness
- **Coverage:** 15+ DMS datasets across prokaryotic and eukaryotic proteins
- **Correlation:** Spearman correlation with experimental measurements
- **Advantage:** Works on both coding and noncoding RNA fitness

## 2. Generative API Capabilities

### 2.1 Unconstrained Sequence Generation
**Core Mechanism:** Autoregressive generation with genomic prompts
- **Scale:** From gene fragments to complete genomes (16kb mitochondrial to 580kb bacterial)
- **Quality Control:** Maintains genomic structure, gene content, synteny
- **Applications:** Gene design, minimal genome construction, synthetic biology

**API Pattern:**
```python
def generate_sequence(prompt_sequence, max_length, temperature=1.0):
    generated = model.generate(
        prompt=prompt_sequence,
        max_new_tokens=max_length,
        temperature=temperature
    )
    return generated
```

### 2.2 Controllable Generation via Inference-Time Search
**Core Mechanism:** Beam search with external scoring functions
- **Architecture:** Ensemble scoring with Enformer/Borzoi for epigenomic properties
- **Efficiency:** 128bp chunks with progressive evaluation
- **Scaling:** Predictable performance improvement with increased compute
- **Applications:** Epigenomic design, chromatin accessibility engineering

### 2.3 Generative Epigenomics
**Core Mechanism:** Inference-time optimization for functional properties
- **Method:** Gradient-free optimization through beam search
- **Design Space:** Chromatin accessibility patterns, Morse code encoding
- **Novelty:** First demonstration of inference-time scaling in biology
- **Token Efficiency:** Achieves AUROC >0.9 with 30+ chunk sampling

**API Pattern:**
```python
def design_epigenomic_sequence(target_pattern, context_genome, max_compute_tokens):
    # Beam search with external scoring
    designs = model.beam_search_generate(
        prompt=context_genome,
        scoring_fn=lambda seq: epigenome_scorer(seq, target_pattern),
        beam_width=30,
        chunk_size=128
    )
    return designs[0]  # Best scoring design
```

## 3. Technical Architecture Insights

### 3.1 Model Architecture
- **StripedHyena 2:** Multi-hybrid convolutional architecture
- **Context Window:** Up to 1M tokens (1M bp) with progressive extension
- **Training:** Two-phase (pretraining + midtraining) with data augmentation
- **Scale:** 7B and 40B parameter models trained on 9.3T tokens

### 3.2 Key Innovations
- **Multi-modal Learning:** DNA, RNA, protein representations from sequence alone
- **Long-context Processing:** Effective retrieval from 1M token haystacks
- **Inference-time Scaling:** More compute = better designs (first in biology)
- **Safety by Design:** Excludes eukaryotic viral sequences from training

## 4. Performance Benchmarks

### 4.1 Discriminative Performance
| Task | Evo 2 40B | Evo 2 7B | State-of-Art |
|------|-----------|----------|--------------|
| Noncoding VEP (SNVs) | **0.85 AUROC** | 0.84 AUROC | 0.83 (GPN-MSA) |
| Noncoding VEP (non-SNVs) | **0.78 AUROC** | 0.77 AUROC | N/A |
| Splice Prediction | **0.82 AUROC** | 0.81 AUROC | 0.79 (SpliceAI) |
| BRCA1 Classification | **0.94 AUROC** | 0.93 AUROC | 0.91 (AlphaMissense) |

### 4.2 Generative Performance
- **Mitochondrial Genome:** Complete 16kb generation with proper gene content
- **Bacterial Genome:** 580kb M. genitalium with 70% Pfam hits
- **Eukaryotic Genome:** 316kb yeast chromosome with realistic structure
- **Epigenomic Design:** AUROC 0.9+ for chromatin accessibility patterns

## 5. API Design Recommendations

### 5.1 Discriminative Endpoints
```python
POST /predict/variant-impact
POST /predict/pathogenicity  
POST /predict/gene-essentiality
POST /predict/protein-fitness
POST /classify/brca-variants
```

### 5.2 Generative Endpoints
```python
POST /generate/sequence
POST /generate/gene
POST /design/epigenome
POST /generate/genome
```

### 5.3 Analysis Endpoints
```python
POST /analyze/sequence-likelihood
POST /analyze/mutation-effects
POST /interpret/features
```

## 6. Strategic Implications

### 6.1 Competitive Advantages
- **Universal Coverage:** Works across all domains of life (bacteria to humans)
- **Zero-shot Capability:** No task-specific fine-tuning required
- **Long Context:** Can process entire genomes in single forward pass
- **Safety Built-in:** Cannot generate eukaryotic viral sequences

### 6.2 Market Opportunities
- **Drug Discovery:** Target identification, safety prediction
- **Synthetic Biology:** Gene design, minimal genome construction  
- **Clinical Diagnostics:** Variant interpretation, personalized medicine
- **Agricultural Biotech:** Crop improvement, trait optimization

### 6.3 Technical Moats
- **Data Advantage:** OpenGenome2 (8.8T nucleotides) vs competitors
- **Architectural Innovation:** StripedHyena 2 efficiency
- **Training Scale:** 40B parameters, 9.3T tokens
- **Inference-time Scaling:** Predictable improvement with compute

## Conclusion

Evo 2 represents a fundamental advance in biological AI, providing both discriminative and generative capabilities that enable comprehensive genomic analysis and design. The model's ability to operate across all scales (molecular to organismal) and domains of life, combined with its zero-shot capabilities and inference-time scaling, positions it as a uniquely powerful tool for computational biology and synthetic biology applications.

The API capabilities analyzed here provide the foundation for building sophisticated biological design and analysis platforms that can accelerate drug discovery, synthetic biology, and clinical applications.

## 7. Advanced Technical Deep Dive

### 7.1 Inference-Time Search Architecture

**Beam Search Implementation:**
- **Chunk Size:** 128 bp per generation step
- **Scoring Frequency:** After each 128 bp chunk
- **Ensemble Scoring:** Enformer + Borzoi (5 models total)
- **Pattern Specification:** Binary vectors defining accessibility profiles

**Scoring Function Details:**
```python
def epigenome_scorer(sequence, target_pattern):
    # Enformer scoring (196,608 bp context)
    enformer_input = concat(upstream_40960bp, sequence, downstream_40960bp)
    enformer_preds = enformer.predict(enformer_input)  # Shape: (896,)
    enformer_score = l1_distance(target_pattern, normalize(enformer_preds))
    
    # Borzoi scoring (524,288 bp context) 
    borzoi_input = concat(upstream_163840bp, sequence, downstream_163840bp)
    borzoi_preds = ensemble_borzoi.predict(borzoi_input)  # Shape: (6144,)
    borzoi_score = l1_distance(upsample(target_pattern), normalize(borzoi_preds))
    
    return (enformer_score + borzoi_score) / 2
```

### 7.2 Scaling Laws in Biological Design

**First Demonstration of Inference-Time Scaling:**
- **Metric:** Log-linear relationship between compute and design quality
- **Compute Proxy:** Number of chunks sampled per beam search iteration
- **Quality Metric:** AUROC for target vs. predicted accessibility patterns
- **Implication:** More inference compute = better biological designs

**Performance Scaling:**
| Chunks Sampled | AUROC | Token Efficiency |
|----------------|-------|------------------|
| 1 (greedy) | 0.75 | 1.0 tok/bp |
| 10 | 0.82 | 10.0 tok/bp |
| 30+ | 0.90+ | 30.0+ tok/bp |

### 7.3 Model Architecture Innovations

**StripedHyena 2 Key Features:**
- **Multi-Hybrid Operators:** Short Explicit (SE), Medium Regularized (MR), Long Implicit (LI)
- **Convolutional Focus:** Input-dependent convolutions enable efficient long-sequence processing
- **Throughput:** 1.3× speedup at 16k context, 3× at 1M context vs. Transformers
- **Training Efficiency:** Lower loss scaling across different sequence lengths

**Context Extension Protocol:**
- **Phase 1:** Pretraining at 8,192 context (2.4T tokens for 7B model)
- **Phase 2:** Progressive extension to 1M context (6.9T additional tokens)
- **RoPE Adaptation:** 10× base frequency increase per 2× context length
- **Stability:** Maintains performance across extension phases

### 7.4 Safety and Controllability Features

**Built-in Safety Mechanisms:**
- **Data Exclusion:** No eukaryotic viral sequences in training data
- **Generation Control:** Cannot generate functional eukaryotic viral proteins
- **Verification:** 10,000 random seeds tested - all generate random/nonsense viral sequences

**Controllability Features:**
- **Prompt Engineering:** Genomic context enables realistic generations
- **Inference-Time Guidance:** External scoring functions for functional objectives
- **Beam Search Control:** Adjustable beam width for quality vs. speed tradeoffs

### 7.5 Computational Requirements

**Training Infrastructure:**
- **Scale:** 40B parameters trained on 9.3T tokens
- **Hardware:** Multi-GPU with tensor parallelism
- **Architecture:** StripedHyena 2 with custom context-parallel algorithms

**Inference Requirements:**
- **Memory:** 40B model requires substantial GPU memory
- **Beam Search:** Additional compute for multiple sequence candidates
- **External Models:** Enformer/Borzoi require additional GPU resources

## 8. API Implementation Strategy

### 8.1 Recommended Endpoint Structure

**Core Discriminative Endpoints:**
```python
POST /api/v1/predict/variant-impact
- Input: {sequence_wt, sequence_mut, context_window}
- Output: {delta_score, pathogenicity_confidence}

POST /api/v1/predict/gene-essentiality  
- Input: {gene_sequence, organism_context}
- Output: {essentiality_score, confidence_interval}

POST /api/v1/classify/brca-variants
- Input: {variants_list, supervised_model_version}
- Output: {lof_predictions, functional_predictions}
```

**Core Generative Endpoints:**
```python
POST /api/v1/generate/genome
- Input: {prompt_sequence, target_length, temperature}
- Output: {generated_sequence, quality_metrics}

POST /api/v1/design/epigenome
- Input: {target_pattern, genomic_context, beam_width}
- Output: {designed_sequence, auroc_score, consensus_score}
```

### 8.2 Production Considerations

**Scalability:**
- **Model Serving:** Multiple model sizes (7B/40B) for different use cases
- **Caching:** KV-cache optimization for StripedHyena 2
- **Batching:** Efficient sequence packing for training efficiency

**Quality Control:**
- **Validation:** Cross-reference with known biological constraints
- **Filtering:** Remove sequences with pathological properties
- **Post-processing:** Structural validation with AlphaFold 3

## 9. Strategic Market Position

### 9.1 Competitive Differentiation

**Technical Advantages:**
- **Universal Model:** Single model for all biological domains vs. specialized tools
- **Zero-Shot Learning:** No fine-tuning required vs. task-specific models
- **Long Context:** Process entire genomes vs. fragment-based approaches
- **Inference Scaling:** Predictable improvement with compute vs. static performance

**Data Advantages:**
- **OpenGenome2:** 8.8T nucleotides vs. smaller datasets
- **Multi-Domain Coverage:** Bacteria to humans vs. single-species focus
- **Full Open Source:** Training code + data + models vs. closed systems

### 9.2 Target Applications

**High-Value Use Cases:**
1. **Drug Discovery:** Target identification, safety prediction, resistance modeling
2. **Synthetic Biology:** Gene design, minimal genome construction, metabolic engineering  
3. **Clinical Genomics:** Variant interpretation, disease risk prediction, therapeutic design
4. **Agricultural Biotech:** Crop improvement, trait optimization, synthetic biology

**Enterprise Value:**
- **Time Savings:** From months to hours for design tasks
- **Success Rate:** Improved hit rates through better predictions
- **Cost Reduction:** Fewer experimental iterations required

## 10. Conclusion & Future Directions

Evo 2 represents the most advanced biological foundation model to date, offering unprecedented capabilities in both discriminative prediction and generative design. The model's ability to operate across all scales of biological complexity, combined with its zero-shot learning capabilities and demonstrated inference-time scaling, establishes it as the foundation for the next generation of computational biology tools.

**Key Takeaways:**
- **API-First Design:** The model's capabilities naturally map to production-ready endpoints
- **Scaling Laws:** First demonstration of inference-time scaling in biological design
- **Safety Built-in:** Responsible design prevents misuse while enabling legitimate applications
- **Universal Utility:** Single model serves diverse applications from drug discovery to synthetic biology

**Next Steps:**
- **Production Deployment:** Implement scalable inference infrastructure
- **Application Development:** Build domain-specific interfaces for key use cases
- **Community Integration:** Develop tools for the broader research community
- **Model Evolution:** Continue scaling and expanding capabilities

This analysis provides the comprehensive foundation needed to build and deploy Evo 2's capabilities in production environments, enabling the next revolution in computational biology and synthetic biology applications.
